Quick Takeaways
- ROYCE & ASSOCIATES LP filed SCHEDULE 13G/A for Apyx Medical Corporation Common Stock (APYX).
- Disclosed ownership: 6%.
- Date of event: 31 Dec 2025.
ROYCE & ASSOCIATES LP - 31 Dec 2025 SCHEDULE 13G/A Report for Apyx Medical Corporation Common Stock (APYX)
- Filing Manager
- ROYCE & ASSOCIATES LP
- Reporting Manager
- ROYCE & ASSOCIATES LP
- Symbol
- APYX
- Shares outstanding
- 41,059,412 shares
- Disclosed Ownership
- 2,443,035 shares
- Ownership
- 6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 20 Jan 2026, 10:02:57 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ROYCE & ASSOCIATES LP disclosed 6% ownership in Apyx Medical Corporation Common Stock (APYX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Jan 2026, 10:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ROYCE & ASSOCIATES LP | 6% | 2,443,035 | 2,443,035 | 0 | Daniel A. O'Byrne | Vice President |